Personalized marrow-derived cell therapy
Total Trials
9
As Lead Sponsor
6
As Collaborator
3
Total Enrollment
1,126
NCT00507468
Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2005
Completion: Aug 31, 2009
NCT02438306
CardiAMP™ Cell Therapy for Heart Failure Trial
Phase: Phase 3
Start: Dec 31, 2016
Completion: Jun 30, 2025
NCT05066581
Vitoria Sleep Smart City: Interactive Intervention for Sleep Improvement
Phase: N/A
Role: Collaborator
Start: Jun 21, 2021
Completion: Nov 30, 2022
NCT03455725
CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
Start: Jun 30, 2021
Completion: Dec 31, 2026
NCT05192564
Exercise and Vestibular Hypofunction
Start: Jan 8, 2022
Completion: Jul 30, 2024
NCT06975631
Post-market Study on TrHCROSS® in Knee Osteoarthritis After a Single Injection
Start: Jun 2, 2022
Completion: Feb 14, 2024
NCT05925608
Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells
Phase: Phase 1/2
Start: Aug 23, 2023
Completion: Jul 31, 2025
NCT06258447
CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction
Start: Aug 1, 2024
Completion: Apr 1, 2029
NCT05491681
AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial
Start: Aug 31, 2024
Completion: Dec 31, 2025
Loading map...